Stocks and Investing Stocks and Investing
Tue, October 24, 2023
Mon, October 23, 2023

David Nierengarten Reiterated (STRO) at Buy and Held Target at $12 on, Oct 23rd, 2023


Published on 2024-10-28 07:02:15 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $12 on, Oct 23rd, 2023.

David has made no other calls on STRO in the last 4 months.



There are 4 other peers that have a rating on STRO. Out of the 4 peers that are also analyzing STRO, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $10 on, Friday, October 6th, 2023
  • Asthika Goonewardene of "Truist Securities" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, September 6th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $17 on, Monday, August 14th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $16 on, Friday, August 11th, 2023
Contributing Sources